SARC Participant Login
Home
About SARC
SARC Sarcoma Trials
About Sarcoma
Sarcoma Patients & Families
Sarcoma Clinical Trials
SARC's Medical Community
Contribute to Sarcoma Research
Career Development Award 2010
SARC Site Map
SARC Site Map
Web Pages
Home
About SARC
SARC Vision and Mission
SARC History
SARC Staff and Board of Directors
SARC Staff Information
Laurence Baker, DO
Denise Reinke, MS, NP
SARC Sarcoma Institutions
SARC Sarcoma Trials
Open Sarcoma Trials
SARC 006: MPSNT
SARC 009: Advanced Sarcomas
SARC 011: Refractory Sarcomas
SARC 012: Recurrent Osteosarcoma
Closed Sarcoma Trials
SARC 001 Manuscript
SARC 002: Metastatic Soft Tissue Sarcomas
SARC 003
SARC 004: DFSP
SARC 005: Leiomyosarcoma
SARC 007: Chemo-Insensitive Sarcomas
SARC Map
About Sarcoma
Sarcoma Causes, Risk Factors and Prevention
Sarcoma Grades and Stages
Sarcoma Diagnosis
Sarcoma Genetic Markers
Sarcoma Treatment Options
New Agents for Sarcoma Treatment
Multidisciplinary Team
Patient Guide to Treatment Based on NCCN Guidelines: Bone Cancer
Sarcoma Glossary
Bone Sarcoma
Soft Tissue Sarcoma
Is There A Cure?
Sarcoma Patients & Families
Helpful Tips
Caregiving
Caregiver Presentation
Patient and Family Online Resources
Contact Us
Cautious Web-Browsing
Sarcoma Recurrence
Palliative Care
Sarcoma Clinical Trials
Clinical Trials Types
Clinical Trial Team
Key Terms
Trial Phases
Patient Experience in a Trial
How to Join a Trial
Patients' Expenses
Patient Privacy
Completion of the Trial
SARC's Medical Community
SARC Semiannual Meetings
Past SARC Meetings
2007 and 2008 SARC Meetings
2008 ASCO Sarcoma Summary
Find A SARC Specialist
Contribute to Sarcoma Research
Friend of SARC Award
Thank You for Your Donation
Advocate
Another Way to Help
PayPal Donations
Career Development Award 2010
Interactive Map
Terms of Use
Contact Us
News
Roche/Genetech decide to halt development of their IGF-1R antibody
SARC Meeting Agenda for November 5, 2009
SARC Announces Career Development Award Timeline 2010
SARC Announces Career Development Award Recipients 2009
SARC Meeting Agenda for May 29, 2009
Request for Osteosarcoma Research Proposals
8,000 People Join the Team Sarcoma Initiative to Fight a Rare Cancer
SARC Physician Honored by Sarcoma Foundation of America
SARC Announces Career Development Award
Facebook Causes Challenge Helps Raise Awareness for Rare Cancer Types
CancerCare Connect Call: Sarcoma Health and Education Workshop
Roche Announces Positive Results in IGF-1R (R1507) Study and Plans for Future SARC Studies
Across the world, people ‘virtually’ come together to fight sarcoma; Ann Arbor event set for July 7
Results of Sarcoma Alliance for Research Through Collaboration Study 002
U-M oncologist and SARC President receives Sarcoma Foundation of America's Nobility in Science Award
Keryx Biopharmaceuticals, Inc. Commences Phase II, in Collaboration with SARC
Liddy Shriver Grant to Fund SARC Study
Articles
Insulin-like growth factor-I receptor activation blocks doxorubicin cytotoxicity in sarcoma cells
Antitumor Activity of the Insulin-Like Growth Factor-I Receptor Kinase Inhibitor NVP-AEW541 in Musculoskeletal Tumors
A Look At Bone Sarcomas Past and Present
Rhabdomyosarcoma: New Windows of Opportunity
The Growing Role of the mTOR Pathway
Cancer Treatment Related Changes in Cognitive Function (a.k.a. "Chemo Brain")
New Emerging Drugs in Soft Tissue Sarcoma
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Soft Tissue Sarcoma
Cancer Pathway Exposed
Evidence-Based Recommendations for Local Therapy for Soft Tissue Sarcomas
Practical Bayesian Adaptive Randomization in Clinical Trials
Treatment of Advanced Soft Tissue Sarcoma: Conventional Agents and Promising New Drugs
Optimizing Treatment of Desmoid Tumors
Multiple Drug Resistance in Osteogenic Sarcoma: INT0133 From the Children's Oncology Group
Gemcitabine and Docetaxel in Metastatic Sarcoma: Past, Present, and Future
Survival for Soft Tissue Sarcoma Patients Improved at High-volume Centers
Gastrointestinal Stromal Tumours and Imatinib
Pediatric sarcomas occurring in adults
SARC: An Effort to Perform Clinical Trials More Efficiently and Effectively for People with Sarcoma
Therapeutic Potential of Directed Tyrosine Kinase Inhibitor Therapy in Sarcomas
Chordoma: The Nonsarcoma Primary Bone Tumor
Variability in the presentation of synovial sarcoma in children
Soft tissue sarcoma in Treating Pediatric soft tissue sarcomas in a country with limited resources: The experience of the Unidad Nacional de Oncologia Pediatrica in Guatemala
Advances in treating soft tissue sarcoma
Sitemap
|
Terms of Use
|
Contact SARC
|
Contact Webmaster
SARC | 24 Frank Lloyd Wright Drive, Lobby A, Suite 3100 | Ann Arbor, MI 48106 | phone 734.930.7600 | fax 734.930.7557